慢性阻塞性肺疾病急性加重患者中的非呼吸机相关ICU获得性肺炎:来自法国OUTCOMEREA队列
本研究基于法国OUTCOMEREA ICU数据库,纳入844例未立即接受有创机械通气的慢性阻塞性肺疾病急性加重(AECOPD)患者,采用竞争风险生存分析探讨非呼吸机相关ICU获得性肺炎(NV-ICU-AP)发生的相关因素及其与预后的关联。结果显示NV-ICU-AP发生于42例(5%),发生密度为10.8/1000患者日;入ICU时使用抗生素(sHR 0.45 [0.23; 0.86],p=0.02)和无意识水平下降(sHR 0.35 [0.16; 0.76],p<0.01)与NV-ICU-AP风险降低相关。校正混杂因素后,NV-ICU-AP与28天死亡率升高(HR 3.03 [1.36; 6.73],p<0.01)、插管风险升高(csHR 5.00 [2.54; 9.85],p<0.01)及ICU住院时间延长10天(p<0.01)相关。
要点
- 844例未立即有创通气的AECOPD患者中,NV-ICU-AP发生42例(5%),发生密度10.8/1000患者日。
- 入ICU时使用抗生素与NV-ICU-AP风险降低相关(sHR 0.45 [0.23; 0.86],p=0.02)。
- 无意识水平下降与NV-ICU-AP风险降低相关(sHR 0.35 [0.16; 0.76],p<0.01)。
- NV-ICU-AP与28天死亡率升高(HR 3.03 [1.36; 6.73],p<0.01)和插管风险升高(csHR 5.00 [2.54; 9.85],p<0.01)相关。
- NV-ICU-AP与ICU住院时间延长10天相关(p<0.01)。
适用人群与场景
- 因慢性阻塞性肺疾病急性加重(AECOPD)入住ICU、未立即接受有创机械通气的患者。
研究设计与关键结果
- 研究类型:基于法国ICU数据库OutcomeRea™的队列研究,纳入844例未立即接受有创机械通气的AECOPD患者。
- NV-ICU-AP发生于42例(5%),发生密度为10.8/1000患者日。
- 多因素分析:入ICU时使用抗生素与NV-ICU-AP风险降低相关(sHR 0.45 [0.23; 0.86],p=0.02);无意识水平下降与NV-ICU-AP风险降低相关(sHR 0.35 [0.16; 0.76],p<0.01)。
- 校正混杂因素后,NV-ICU-AP与28天死亡率升高相关(HR 3.03 [1.36; 6.73],p<0.01)。
- 校正混杂因素后,NV-ICU-AP与插管风险升高相关(csHR 5.00 [2.54; 9.85],p<0.01)。
- 校正混杂因素后,NV-ICU-AP与ICU住院时间延长10天相关(p<0.01)。
证据类型、等级与局限
- 证据类型:基于法国ICU数据库OutcomeRea™的队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在因AECOPD入住ICU且未立即有创通气的患者中,NV-ICU-AP发生率为5%(42/844),发生密度10.8/1000患者日,提示需关注此类患者院内肺炎的发生。
- NV-ICU-AP与插管风险升高(csHR 5.00 [2.54; 9.85],p<0.01)、28天死亡率升高(HR 3.03 [1.36; 6.73],p<0.01)及ICU住院时间延长10天(p<0.01)相关。
- 入ICU时使用抗生素与NV-ICU-AP风险降低相关(sHR 0.45 [0.23; 0.86],p=0.02),无意识水平下降与NV-ICU-AP风险降低相关(sHR 0.35 [0.16; 0.76],p<0.01)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Non-ventilator-associated ICU-acquired pneumonia (NV-ICU-AP), a nosocomial pneumonia that is not related to invasive mechanical ventilation (IMV), has been less studied than ventilator-associated pneumonia, and never in the context of patients in an ICU for severe acute exacerbation of chronic obstructive pulmonary disease (AECOPD), a common cause of ICU admission. This study aimed to determine the factors associated with NV-ICU-AP occurrence and assess the association between NV-ICU-AP and the outcomes of these patients.
METHODS: Data were extracted from the French ICU database, OutcomeRea™. Using survival analyses with competing risk management, we sought the factors associated with the occurrence of NV-ICU-AP. Then we assessed the association between NV-ICU-AP and mortality, intubation rates, and length of stay in the ICU.
RESULTS: Of the 844 COPD exacerbations managed in ICUs without immediate IMV, NV-ICU-AP occurred in 42 patients (5%) with an incidence density of 10.8 per 1,000 patient-days. In multivariate analysis, prescription of antibiotics at ICU admission (sHR, 0.45 [0.23; 0.86], p = 0.02) and no decrease in consciousness (sHR, 0.35 [0.16; 0.76]; p < 0.01) were associated with a lower risk of NV-ICU-AP. After adjusting for confounders, NV-ICU-AP was associated with increased 28-day mortality (HR = 3.03 [1.36; 6.73]; p < 0.01), an increased risk of intubation (csHR, 5.00 [2.54; 9.85]; p < 0.01) and with a 10-day increase in ICU length of stay (p < 0.01).
CONCLUSION: We found that NV-ICU-AP incidence reached 10.8/1000 patient-days and was associated with increased risks of intubation, 28-day mortality, and longer stay for patients admitted with AECOPD.
参考来源
- Galerneau LM, Bailly S, Terzi N, et al. Non-ventilator-associated ICU-acquired pneumonia (NV-ICU-AP) in patients with acute exacerbation of COPD: From the French OUTCOMEREA cohort. Crit Care. 2023. PMID: 37726796. doi:10.1186/s13054-023-04631-2
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。